These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9356045)

  • 1. No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes.
    Okazawa H; Mori H; Tamori Y; Araki S; Niki T; Masugi J; Kawanishi M; Kubota T; Shinoda H; Kasuga M
    Diabetes; 1997 Nov; 46(11):1904-6. PubMed ID: 9356045
    [No Abstract]   [Full Text] [Related]  

  • 2. Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes.
    Vigouroux C; Fajas L; Khallouf E; Meier M; Gyapay G; Lascols O; Auwerx J; Weissenbach J; Capeau J; Magré J
    Diabetes; 1998 Mar; 47(3):490-2. PubMed ID: 9519760
    [No Abstract]   [Full Text] [Related]  

  • 3. Mutations of the peroxisome proliferator-activated receptor gamma (PPAR gamma) gene in a Japanese population : the Pro12Ala mutation in PPAR gamma 2 is associated with lower concentrations of serum total and non-HDL cholesterol.
    Iwata E; Matsuda H; Fukuda T; Fukuen S; Motomura T; Igarashi T; Yamamoto I; Azuma J
    Diabetologia; 2001 Oct; 44(10):1354-5. PubMed ID: 11692187
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of the insulin-sensitive phosphodiesterase 3B gene in type 2 diabetes.
    Sano R; Miki T; Suzuki Y; Shimada F; Taira M; Kanatsuka A; Makino H; Hashimoto N; Saito Y
    Diabetes Res Clin Pract; 2001 Nov; 54(2):79-88. PubMed ID: 11640991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms.
    Zhu Y; Qi C; Korenberg JR; Chen XN; Noya D; Rao MS; Reddy JK
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7921-5. PubMed ID: 7644514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
    Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of three missense mutations in the peroxisome proliferator-activated receptor alpha gene in Japanese subjects with maturity-onset diabetes of the young.
    Hara M; Wang X; Paz VP; Iwasaki N; Honda M; Iwamoto Y; Bell GI
    J Hum Genet; 2001; 46(5):285-8. PubMed ID: 11355020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of mutations in the hepatocyte nuclear factor (HNF)-1 alpha gene in Japanese subjects with IDDM.
    Yamada S; Nishigori H; Onda H; Utsugi T; Yanagawa T; Maruyama T; Onigata K; Nagashima K; Nagai R; Morikawa A; Takeuchi T; Takeda J
    Diabetes; 1997 Oct; 46(10):1643-7. PubMed ID: 9313763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with lipodystrophic diabetes mellitus of the Seip-Berardinelli type, express normal insulin receptors.
    van der Vorm ER; Kuipers A; Bonenkamp JW; Kleijer WJ; Van Maldergem L; Herwig J; Maassen JA
    Diabetologia; 1993 Feb; 36(2):172-4. PubMed ID: 8458533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoatrophic diabetes: genetic exclusion of the insulin receptor gene.
    Desbois-Mouthon C; Magré J; Amselem S; Reynet C; Blivet MJ; Goossens M; Capeau J; Besmond C
    J Clin Endocrinol Metab; 1995 Jan; 80(1):314-9. PubMed ID: 7829633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene.
    Beamer BA; Negri C; Yen CJ; Gavrilova O; Rumberger JM; Durcan MJ; Yarnall DP; Hawkins AL; Griffin CA; Burns DK; Roth J; Reitman M; Shuldiner AR
    Biochem Biophys Res Commun; 1997 Apr; 233(3):756-9. PubMed ID: 9168928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved insulin-sensitivity in mice heterozygous for PPAR-gamma deficiency.
    Miles PD; Barak Y; He W; Evans RM; Olefsky JM
    J Clin Invest; 2000 Feb; 105(3):287-92. PubMed ID: 10675354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor substrate-1 gene variants in lipoatrophic diabetes mellitus and non-insulin-dependent diabetes mellitus: a study of South African black and white subjects.
    Panz VR; Raal FJ; O'Rahilly S; Kedda MA; Joffe BI
    Hum Genet; 1997 Nov; 101(1):118-9. PubMed ID: 9385382
    [No Abstract]   [Full Text] [Related]  

  • 15. Retinoid X receptor heterodimers in the metabolic syndrome.
    Hegele RA
    N Engl J Med; 2005 Nov; 353(19):2088. PubMed ID: 16282190
    [No Abstract]   [Full Text] [Related]  

  • 16. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.
    Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU
    Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
    Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
    Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
    Mancini FP; Vaccaro O; Sabatino L; Tufano A; Rivellese AA; Riccardi G; Colantuoni V
    Diabetes; 1999 Jul; 48(7):1466-8. PubMed ID: 10389855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular scanning of beta-3-adrenergic receptor gene in total congenital lipoatrophic diabetes mellitus.
    Silver K; Walston J; Plotnick L; Taylor SI; Kahn CR; Shuldiner AR
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3395-8. PubMed ID: 9329375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the hepatocyte nuclear factor-1alpha gene in MODY and early-onset NIDDM: evidence for a mutational hotspot in exon 4.
    Kaisaki PJ; Menzel S; Lindner T; Oda N; Rjasanowski I; Sahm J; Meincke G; Schulze J; Schmechel H; Petzold C; Ledermann HM; Sachse G; Boriraj VV; Menzel R; Kerner W; Turner RC; Yamagata K; Bell GI
    Diabetes; 1997 Mar; 46(3):528-35. PubMed ID: 9032114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.